Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Blood|February 28, 2013
Erk1 and Erk2 are required for maintenance of hematopoietic stem cells and adult hematopoiesisGordon Chan, Shengqing Gu, Benjamin G NeelInfectious Agents and Cancer|May 23, 2019
PIVKA-II level is correlated to development of portal vein tumor thrombus in patients with HBV-related hepatocellular carcinomaTao Li, Yuanzi Yu, Juan Liu, et al.Blood|January 17, 2016
Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1Shengqing Gu, Wayne W Chan, Golam Mohi, et al.Molecular and Cellular Biology|July 25, 2012
Increased BRAF heterodimerization is the common pathogenic mechanism for noonan syndrome-associated RAF1 mutantsXue Wu, Jiani Yin, Jeremy Simpson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2020
Inhibition of MAN2A1 Enhances the Immune Response to Anti-PD-L1 in Human TumorsSailing Shi, Shengqing Gu, Tong Han, et al.Cancer Discovery|November 7, 2020
Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian CancerShuang Zhang, Sonia Iyer, Hao Ran, et al.Genomics, Proteomics & Bioinformatics|December 9, 2022
Machine Learning Modeling of Protein-intrinsic Features Predicts Tractability of Targeted Protein DegradationWubing Zhang, Shourya S Roy Burman, Jiaye Chen, et al.Genomics, Proteomics & Bioinformatics|July 20, 2021
CoBRA: Containerized Bioinformatics Workflow for Reproducible ChIP/ATAC-seq AnalysisXintao Qiu, Avery S Feit, Ariel Feiglin, et al.Cell|December 14, 2011
Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubismNoam Levaot, Oleksandr Voytyuk, Ioannis Dimitriou, et al.Nature Medicine|August 22, 2018
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy responsePeng Jiang, Shengqing Gu, Deng Pan, et al.Pageof 3